Translation, cross-cultural adaptation and measurement proprieties of the German version of the Allodynia Symptom Checklist (ASC-12).


Journal

The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 17 10 2023
accepted: 27 11 2023
medline: 4 12 2023
pubmed: 2 12 2023
entrez: 1 12 2023
Statut: epublish

Résumé

Cutaneous allodynia is highly prevalent among migraineurs and is associated with a poor prognosis. The Allodynia Symptom Checklist (ASC-12) is a comprehensive questionnaire to identify the presence and severity of allodynia. Our aim was to translate and adapt the ASC-12 to German and evaluate its measurement properties. Following the COSMIN guidelines, 80 migraine patients were enrolled in the study to evaluate the stages of translation (n=30) and measurement propriety assessment (n=50), respectively. After reaching a final version, the German ASC-12 was assessed for structural validity, internal consistency, test-retest reliability, construct validity and absolute agreement, using mechanical and thermal pain thresholds as reference method. The German version of the ASC-12 presented an adequate structural validity compatible with the original version of the questionnaire. Its internal consistency ranged from 0.70 to 0.80 considering the total score and the thermic, static and dynamic mechanic subdomains. The total score presented excellent reliability (ICC: 0.85) with a standard error of measurement of 1.15 points and smallest detectable change of 3.40 points. ASC-12 total scores were correlated with headache intensity (r=0.38, p=0.004), headache disability (r=0.37, p=0.004) and cold pain thresholds (r=0.28, p=0.025). The thermic allodynia ASC-12 scores were correlated with cold (r=0.36, p=0.005) and heat (r=-0.30, p=0.010) pain thresholds, while the static mechanical allodynia ASC-12 scores correlated with mechanical pain threshold (r=0.29, p=0.019) and with mechanical pain sensitivity (r=0.24 to 0.28, p< 0.045). Despite no significant bias between methods, quantitative sensory testing (QST) results and ASC-12 scores tend to disagree. The German version of the ASC-12 is available for research and clinical settings and presented adequate measurement proprieties, as the original version. Despite the correlation between the ASC-12 and QST, one method cannot be replaced by the other.

Sections du résumé

BACKGROUND BACKGROUND
Cutaneous allodynia is highly prevalent among migraineurs and is associated with a poor prognosis. The Allodynia Symptom Checklist (ASC-12) is a comprehensive questionnaire to identify the presence and severity of allodynia. Our aim was to translate and adapt the ASC-12 to German and evaluate its measurement properties.
METHODS METHODS
Following the COSMIN guidelines, 80 migraine patients were enrolled in the study to evaluate the stages of translation (n=30) and measurement propriety assessment (n=50), respectively. After reaching a final version, the German ASC-12 was assessed for structural validity, internal consistency, test-retest reliability, construct validity and absolute agreement, using mechanical and thermal pain thresholds as reference method.
RESULTS RESULTS
The German version of the ASC-12 presented an adequate structural validity compatible with the original version of the questionnaire. Its internal consistency ranged from 0.70 to 0.80 considering the total score and the thermic, static and dynamic mechanic subdomains. The total score presented excellent reliability (ICC: 0.85) with a standard error of measurement of 1.15 points and smallest detectable change of 3.40 points. ASC-12 total scores were correlated with headache intensity (r=0.38, p=0.004), headache disability (r=0.37, p=0.004) and cold pain thresholds (r=0.28, p=0.025). The thermic allodynia ASC-12 scores were correlated with cold (r=0.36, p=0.005) and heat (r=-0.30, p=0.010) pain thresholds, while the static mechanical allodynia ASC-12 scores correlated with mechanical pain threshold (r=0.29, p=0.019) and with mechanical pain sensitivity (r=0.24 to 0.28, p< 0.045). Despite no significant bias between methods, quantitative sensory testing (QST) results and ASC-12 scores tend to disagree.
CONCLUSION CONCLUSIONS
The German version of the ASC-12 is available for research and clinical settings and presented adequate measurement proprieties, as the original version. Despite the correlation between the ASC-12 and QST, one method cannot be replaced by the other.

Identifiants

pubmed: 38041009
doi: 10.1186/s10194-023-01697-9
pii: 10.1186/s10194-023-01697-9
pmc: PMC10693116
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

160

Subventions

Organisme : Medicine Research Committee of the University of Lübeck
ID : H03-2022, FuL-Mittel 2022/2023

Informations de copyright

© 2023. The Author(s).

Références

Headache. 2009 Oct;49(9):1333-44
pubmed: 19788473
Cephalalgia. 2023 Mar;43(3):3331024221147881
pubmed: 36786278
Cephalalgia. 2011 Jan;31(1):6-12
pubmed: 20974609
Clin J Pain. 2008 Jun;24(5):463-6
pubmed: 18496312
Pain. 2019 Jul;160(7):1494-1501
pubmed: 31219950
Pain. 2018 Jul;159(7):1202-1223
pubmed: 29781957
Qual Life Res. 2021 Aug;30(8):2197-2218
pubmed: 33818733
Neurology. 2008 Apr 22;70(17):1525-33
pubmed: 18427069
Brain. 2013 Nov;136(Pt 11):3489-96
pubmed: 24080152
Pain. 2006 Aug;123(3):231-243
pubmed: 16697110
J Neurol. 2017 Apr;264(4):654-663
pubmed: 28154971
Clin Neurol Neurosurg. 2022 Sep;220:107357
pubmed: 35792471
J Headache Pain. 2019 Jan 22;20(1):10
pubmed: 30669961
Eur J Pain. 2019 Nov;23(10):1826-1838
pubmed: 31325385
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Ann Neurol. 2004 Jan;55(1):19-26
pubmed: 14705108
Cephalalgia. 2016 Oct;36(11):1077-1081
pubmed: 26634832
Cephalalgia. 2019 Jun;39(7):873-882
pubmed: 30732460
Pain. 2018 Nov;159(11):2414-2416
pubmed: 30335724
Cephalalgia. 2017 Apr;37(4):305-314
pubmed: 27084886
J Clin Epidemiol. 2004 Dec;57(12):1271-8
pubmed: 15617953
Cephalalgia. 2007 Apr;27(4):325-9
pubmed: 17376108
J Pain Res. 2016 Feb 24;9:101-4
pubmed: 26955290
Clin J Pain. 2009 Oct;25(8):696-8
pubmed: 19920719
Expert Rev Neurother. 2009 Mar;9(3):395-408
pubmed: 19271948
Headache. 2017 Jul;57(7):1026-1040
pubmed: 28603893
Headache. 2006 Jan;46(1):82-91
pubmed: 16412155
PLoS One. 2008;3(11):e3799
pubmed: 19030105
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
Cephalalgia. 2018 Apr;38(4):744-753
pubmed: 28540738
J Clin Epidemiol. 1998 Nov;51(11):945-52
pubmed: 9817111
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Neurol Sci. 2019 Feb;40(2):393-398
pubmed: 30506413
J Headache Pain. 2015;16:529
pubmed: 25968102
Brain. 2000 Aug;123 ( Pt 8):1703-9
pubmed: 10908199
Noro Psikiyatr Ars. 2017 Sep;54(3):260-266
pubmed: 29033640
Arq Neuropsiquiatr. 2012 Nov;70(11):852-6
pubmed: 23175197
Ann Neurol. 2008 Feb;63(2):148-58
pubmed: 18059010
Front Neurol. 2022 Nov 03;13:1032103
pubmed: 36408525
Qual Life Res. 2018 May;27(5):1171-1179
pubmed: 29260445
Sci Rep. 2021 Jan 28;11(1):2467
pubmed: 33510340
Pain Med. 2014 Jan;15(1):154-65
pubmed: 24165094

Auteurs

Tetiana Marusich (T)

Institut für Gesundheitswissenschaften, Studiengang Physiotherapie, Pain and Exercise Research Luebeck (P.E.R.L), Universität zu Lübeck, Lübeck, Deutschland.

Tibor M Szikszay (TM)

Institut für Gesundheitswissenschaften, Studiengang Physiotherapie, Pain and Exercise Research Luebeck (P.E.R.L), Universität zu Lübeck, Lübeck, Deutschland.

Anne Sennholz (A)

Institut für Gesundheitswissenschaften, Studiengang Physiotherapie, Pain and Exercise Research Luebeck (P.E.R.L), Universität zu Lübeck, Lübeck, Deutschland.

Kerstin Luedtke (K)

Institut für Gesundheitswissenschaften, Studiengang Physiotherapie, Pain and Exercise Research Luebeck (P.E.R.L), Universität zu Lübeck, Lübeck, Deutschland. kerstin.luedtke@uni-luebeck.de.

Gabriela F Carvalho (GF)

Department of Physiotherapy, Faculty of Health, Safety and Society, Furtwangen University, Furtwangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH